Announcements Trials
Browse Landscape

Phase

Phase 3 3Phase 4 1

Status

Completed 3

Sponsor Class

OTHER 1NIH 1NETWORK 1

Study Type

Interventional 3

Sponsor

Cancer Type

Other hematologic neoplasm 2Lymphoid 1

Conditions

Mycoses 3Hematologic Neoplasms 3Leukemia 2Invasive Fungal Infections 2Infections 2Myelodysplastic-Myeloproliferative Diseases 1Lymphoma, Follicular 1Lymphoma 1Leukemia, Myeloid, Acute 1Immunologic Deficiency Syndromes 1

Interventions

Voriconazole 3Fluconazole 3Caspofungin 3Levofloxacin 1Amphotericin B 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 3 × Mycoses × Voriconazole × Clear all
NCT01503515 2024-10-16

Caspofungin Acetate, Fluconazole, or Voriconazole in Preventing Fungal Infections in Patients Following Donor Stem Cell Transplant

Children's Oncology Group

Phase 3 Completed
292 enrolled 12 charts
Other hematologic neoplasm

Mycoses, Hematologic Neoplasms

NCT00904995 2012-08-07

Beta Glucan Assay in Patients Receiving Voriconazole Prophylaxis

M.D. Anderson Cancer Center

Phase 3 Completed
23 enrolled 4 charts
Other hematologic neoplasm

Invasive Fungal Infections, Leukemia, Mycoses, Hematologic Neoplasms

NCT00015665 2008-03-04

Emergency Use of Voriconazole in Patients With Life-Threatening Invasive Fungal Infections

National Institutes of Health Clinical Center (CC)

Phase 3 Completed
40 enrolled
Lymphoid

Immunologic Deficiency Syndromes, Infections, Lymphoma, Follicular, Mycoses

Data powered by HemOnc (CC BY 4.0) Colophon âš¡